Detalhe da pesquisa
1.
Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease.
BMC Gastroenterol;
22(1): 464, 2022 Nov 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36384462
2.
Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study.
BMC Gastroenterol;
22(1): 459, 2022 Nov 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36384477
3.
Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway.
Scand J Gastroenterol;
54(8): 1042-1050, 2019 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31424972
4.
Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
Scand J Gastroenterol;
53(10-11): 1347-1353, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30394152
5.
Hepatitis C reinfection after sustained virological response.
J Hepatol;
64(5): 1020-1026, 2016 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26780289
6.
Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.
J Hepatol;
65(6): 1112-1119, 2016 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27542322
7.
Nobel prize for discovery of the hepatitis C virus. / Nobelpris for oppdagelsen av hepatitt C-viruset.
Tidsskr Nor Laegeforen;
140(17)2020 11 24.
Artigo
em Norueguês
| MEDLINE
| ID: mdl-33231386
8.
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.
JHEP Rep;
4(5): 100462, 2022 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35434589
9.
Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.
Eur J Gastroenterol Hepatol;
29(1): 98-104, 2017 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27749779